{"DataElement":{"publicId":"3371441","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical Distant Metastasis M Stage","preferredDefinition":"Extent of the distant metastasis for the thyroid tumor based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3366346v1.0:3371423v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3366346","version":"1","preferredName":"Thyroid Gland Neoplasm Clinical M Stage","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"3366311v1.0:2207806v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3366311","version":"1","preferredName":"Thyroid Gland Neoplasm","preferredDefinition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"C12400:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland","conceptCode":"C12400","definition":"An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B784C9DE-7AB2-3473-E040-BB89AD43638B","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"ONEDATA","dateModified":"2012-01-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207806","version":"1","preferredName":"Clinical M Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25398:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30E1-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B784C9DE-7B16-3473-E040-BB89AD43638B","latestVersionIndicator":"Yes","beginDate":"2012-01-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3371423","version":"1","preferredName":"Thyroid Cancer American Joint Committee on Cancer (AJCC) Edition 7 Clinical M Stage","preferredDefinition":"A clinical finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3371423v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M1","valueDescription":"Thyroid Cancer cM1 TNM Finding v7","ValueMeaning":{"publicId":"3371425","version":"1","preferredName":"Thyroid Cancer cM1 TNM Finding v7","longName":"3371425","preferredDefinition":"Thyroid cancer with distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer cM1 TNM Finding v7","conceptCode":"C89160","definition":"Thyroid cancer with distant metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AC43-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-AC5C-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"},{"value":"M0","valueDescription":"Thyroid Cancer cM0 TNM Finding v7","ValueMeaning":{"publicId":"3371426","version":"1","preferredName":"Thyroid Cancer cM0 TNM Finding v7","longName":"3371426","preferredDefinition":"Thyroid cancer without evidence of distant metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer cM0 TNM Finding v7","conceptCode":"C89159","definition":"Thyroid cancer without evidence of distant metastasis. (from AJCC 7th Ed.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AC68-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8606DF3-AC81-79F6-E040-BB89AD433880","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3371422","version":"1","preferredName":"Thyroid Cancer Clinical Distant Metastasis TNM Finding v7 American Joint Committee on Cancer Stage","preferredDefinition":"A clinical finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89158:C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Cancer Clinical Distant Metastasis TNM Finding v7","conceptCode":"C89158","definition":"A clinical finding about one or more characteristics of thyroid cancer, following the rules of the TNM AJCC v7 classification system as they pertain to distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AC17-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"ONEDATA","dateModified":"2012-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8606DF3-AC28-79F6-E040-BB89AD433880","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"COOPERM","dateModified":"2015-08-27","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3434443","version":"1","longName":"Thyroid","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"10000283","version":"1","longName":"Thyroid","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"THYROID_CLIN_M_STG","type":"COG GDE Short Name","context":"COG"}],"ReferenceDocuments":[{"name":"Clinical M Stage","type":"Preferred Question Text","description":"Clinical M Stage","url":null,"context":"NCI Standards"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"TNM Staging: Clinical M Stage","url":null,"context":"COG"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"B86101DE-B2D7-EB91-E040-BB89AD436932","latestVersionIndicator":"Yes","beginDate":"2012-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-07","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}